Cases


  • All
  • Antitrust Litigation
  • Consumer Protection Litigation
  • Securities Litigation
  • Shareholder Derivative Litigation
  • Shareholder Merger Litigation
  • Employment Practices Litigation
  • Pharmaceutical Litigation
  • Personal Injury Litigation

19 Nov 2018

Sonic Corp. (SONC)

Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Sonic Corp. (SONC) Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Western District of Oklahoma, case ...

Nadeem Faruqi, James M. Wilson, Jr. at New York office

Read more

12 Mar 2018

DST Systems, Inc. (DST)

Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against DST Systems, Inc. Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the District of Delaware, case No. 1:18-cv-00286, ...

James M. Wilson, Jr., Nadeem Faruqi at New York office

Read more

03 Mar 2018

Synergy Pharmaceuticals, Inc. (SGYP)

Faruqi & Faruqi, LLP Files Securities Fraud Class Action Complaint Against Synergy Pharmaceuticals, Inc. With Expanded Class Period Faruqi & Faruqi, LLP, a leading national securities law firm, has filed a federal securities class action complaint against ...

Richard W. Gonnello at New York office

Read more

15 Mar 2017

GoPro, Inc. (GPRO)

Faruqi & Faruqi, LLP Updates GoPro, Inc. (GPRO) Investors Regarding A Federal Securities Class Action Lawsuit On February 6, 2017, Senior District Judge Claudia Wilken of the United States District Court for the Northern District of California appointed ...

Richard W. Gonnello at New York office

Read more

12 Nov 2015

In re Lamictal Direct Purchaser Antitrust Litig., No. 12-00995 (D.N.J.)

In the Lamictal case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of SmithKline Beacham's Lamictal, prescription drugs used to treat epilepsy, bipolar disorder and other medical conditions. The class ...

Joseph T. Lukens, Peter Kohn at New York office

Read more

14 Oct 2015

Smith Drug Co. v. Actavis (Namenda), No. 15-7488 (S.D.N.Y.)

In the Namenda case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Actavis' memantine hydrochloride, sold under the brand name Namenda and Namenda XR. The complaint alleges that Actavis engaged in ...

Joseph T. Lukens, Peter Kohn at New York office

Read more

27 Apr 2015

Emulex Corporation (ELX)

Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Emulex Corporation (ELX) Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Central District of California, ...

Read more

19 Jun 2013

In re Loestrin 24 Fe Antitrust Litig., No. 13-2472 (D.R.I.)

In the Loestrin case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Warner Chilcott's oral contraceptive drug, Loestrin 24 Fe. The class alleges that Warner Chilcott and would-be generic competitors ...

Neill W. Clark, Joseph T. Lukens, Peter Kohn at Pennsylvania office

Read more

05 Apr 2013

In re Niaspan Antitrust Litig., No. 13-cv-1820 (E.D. Pa.)

In the Niaspan case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Abbott Laboratories' triglyceride drug, Niaspan, whose active ingredient is niacin (vitamin B6). Faruqi & Faruqi filed the first direct ...

Joseph T. Lukens, Peter Kohn at Pennsylvania office

Read more

05 Mar 2013

In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litig., No. 13-cv-2445 (E.D. Pa.)

In the Suboxone case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Reckitt Benckiser's opioid addiction drug, Suboxone. The proposed class alleges that Reckitt took several actions to suppress competition ...

Joseph T. Lukens, Peter Kohn at Pennsylvania office

Read more

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885

Delaware

3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612

Georgia

3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania